USPTO serial 79449019
SEPVAZY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 18, 2026
- Examiner
- SEVERSON, JUSTIN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEPVAZY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for prevention and treatment of eye diseases; pharmaceutical preparations for human use for prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for prevention and treatment of kidney diseases; pharmaceutical preparations for human use for prevention and treatment of diabetes; pharmaceutical preparations for human use for prevention and treatment of hypertension; pharmaceutical preparations for human use for prevention and treatment of skin conditions; pharmaceutical preparations for human use in dermatology; pharmaceutical preparations for human use in urology; pharmaceutical preparations for human use in ophthalmology; pharmaceutical preparations for human use for prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for prevention and treatment of allergies; pharmaceutical preparations for human use for prevention and treatment of bone diseases; pharmaceutical preparations for human use for prevention and treatment of respiratory diseases and asthma. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 18, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 30, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 24, 2026 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 4, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 30, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |